CAP TODAY/Illumina Webinar: DNA methylation-based classification of hematolymphoid neoplasms

Thank you

This live web event has ended. Thank you for attending.

Description

DNA methylation-based classification
of hematolymphoid neoplasms

Why should you register now for this webinar?
Hear an expert discuss how DNA methylation profiling classifies
hematolymphoid tumors and subgroups
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Annapurna Saksena, MD

What will this webinar empower you to do?

Understand principles of DNA methylation-based tumor classification
Discuss classification of hematolymphoid (HL) tumors by DNA methylation profiling
Integrate methylation profiles with histological & molecular information
Use of DNA methylation-based classifier as an adjunct test for HL tumors with practical examples
Ask questions of our distinguished presenter

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Illumina.

Contributors

Bob McGonnagle

Publisher, CAP TODAY
Annapurna Saksena, MD

Assistant Professor, Division of Hematopathology
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania